Are there any safety concerns for pregnant women?

Use with caution in pregnant women within months of gestation; further studies are needed to determine teratogenicity.

What is the packaging size and shelf life?

Packaging is 25kg per batch, with an expiry date of 2024.01.01 for the specific batch mentioned.

What payment terms are accepted?

Accepted terms include LC, T/T, D/P, PayPal, Western Union, and small-amount payment.

Hot Selling Sost Artesunate Powder

Name: Hot Selling Sost Artesunate Powder
Brand: Xi an Sost Biotech Co., Ltd.
SKU: 2027826335

Shaanxi, ChinaXi an Sost Biotech Co., Ltd.

US$436.00-437.00

1 KG

Sample price:US$436.70/kg.Request sample

Product profile

Customization

Available

Transport Package

25 Kg/Carton Outside and Double Food Plastic Bags

Specification

98%

Trademark

SOST

Origin

China

Production Capacity

1000 Kg/Momth

Key features

Rapid Malaria Control: Fast-acting derivative effective against Plasmodium vivax and falciparum, controlling acute attacks quickly.

Severe Malaria Treatment: First choice for cerebral malaria, jaundice type, and chloroquine-resistant falciparum malaria cases.

High Purity Standard: Assay result 99.6%, meeting enterprise standards with low impurity levels and high solubility.

Anti-Tumor Potential: Exhibits significant tumor cell-killing effects through inhibiting proliferation and inducing apoptosis.

Water-Soluble Formulation: Only effective artemisinin derivative that can be made into water-soluble preparations for clinical use.

Low Toxic Side Effects: No adverse reactions at recommended doses; transient reticulocyte decrease may occur with high doses.

OEM/ODM Services: Manufacturer offers both OEM and ODM services with 2 R&D engineers and advanced production machines.

Fast Lead Time: Average lead time within 15 workdays for both peak and off-peak seasons.

Company profile

Xi an Sost Biotech Co., Ltd.

Shaanxi, China

CertifiedBusiness Type: Manufacturer/Factory CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2012-11-01 CertifiedNearest Port: Shanghai PortAverage Response Time: ≤3.04h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryXi'an Sost Biotech Co., Ltd. is identified as a China-based manufacturer and trading company focused on herbal extracts, Chinese medicine raw materials, cosmetic ingredients, healthcare ingredients, food additives, and dietary supplement ingredients. Evidence indicates established production, R&D, sales, purchasing, and quality-control functions, with stated GMP-oriented operations, ISO 9001:2015 certification, multiple production bases, and broad export coverage. However, the records contain conflicting production information: one slice reports three production bases and eight lines, while another reports a 2,990 m² plant and two production lines. The supplier states that it provides pre- and after-sales service and accepts several trade and payment terms, but detailed service performance, customization results, customer references, and financial strength are not sufficiently documented. Monetary figures are omitted.

Supplier typeThe supplier is explicitly classified as a manufacturer and limited company, while another record identifies its business nature as a trading company. Its stated activities include R&D, production, sales, and service of herbal extracts and natural raw materials, so it appears to combine manufacturing and trading functions.

CertificationsThe supplier reports ISO 9001:2015 certification and states that production follows national GMP standards, with GMP-standard factories and 100,000-level clean workshops. ISO certification is explicit; the GMP statements are operational claims rather than a separately named certificate.

After-Sales capabilityThe company explicitly emphasizes before-sales and after-sales service, states that it continuously improves service, and describes service as part of its business operations. However, no evidence gives measurable after-sales performance, service staffing, response times, or documented customer outcomes.

R&D capabilityThe supplier reports an R&D department, research and development of high-purity natural products, biological engineering and natural extraction technology, and an innovation-oriented approach. Nevertheless, only two years of R&D engineer experience are reported, and there is no evidence of patents, new-product records, or quantified R&D achievements.

Production capacityProduction capability is supported by a stated manufacturing plant, natural-extract production activities, GMP-oriented facilities, clean workshops, and product lines covering food, healthcare, cosmetics, and pharmaceutical intermediates. The data are inconsistent: one record states three production bases and eight lines, while another reports a 2,990 m² plant and two lines; quality-control staffing is also reported as fewer than five employees.